Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism - Université de Bretagne Occidentale
Article Dans Une Revue Human & Veterinary Medecine Bioflux Année : 2015

Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism

Domaines

Immunologie
Fichier non déposé

Dates et versions

hal-01260185 , version 1 (21-01-2016)

Identifiants

  • HAL Id : hal-01260185 , version 1

Citer

Cristina Bagacean, Naelle Lombion, Adrian Tempescul, Jean-Christophe Ianotto, Christian Berthou, et al.. Diffuse large B-cell lymphoma response rituximab-PMitCEBO regimen is not predicted by FcγRIIa158 polymorphism. Human & Veterinary Medecine Bioflux, 2015, 7 (4), pp.298-301. ⟨hal-01260185⟩

Collections

UNIV-BREST IMMUNO
56 Consultations
0 Téléchargements

Partager

More